Who Invented Ibrance
Developed by Pfizer, Ibrance Targets Proteins in Cancer Cells — Cyclin D Kinase 4 (Cdk 4) and Cyclin D Kinase 6 (Cdk 6) — Preventing the Cells from Dividing...
Developed by Pfizer, Ibrance targets proteins in cancer cells — cyclin D kinase 4 (CDK 4) and cyclin D kinase 6 (CDK 6) — preventing the cells from dividing.
Who discovered Ibrance?
Palbociclib, sold under the brand name Ibrance among others, is a medication developed by Pfizer for the treatment of HR-positive and HER2-negative breast cancer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. Palbociclib was the first CDK4/6 inhibitor to be approved as a cancer therapy.
Who is the manufacturer of Ibrance?
IBRANCE® (palbociclib) Pfizer Oncology Together™ provides financial assistance resources to help patie…
Marcus Vance is a cybersecurity auditor and technology writer dedicated to educating the public about online safety, data privacy regulations, enterprise security, and emerging cyber threats.
